相似文献
1
Immunotherapy in food allergy.
Immunotherapy. 2010 May;2(3):329-38. doi: 10.2217/imt.10.15.
2
Classic specific immunotherapy and new perspectives in specific immunotherapy for food allergy.
Allergy. 2001;56 Suppl 67:121-4. doi: 10.1034/j.1398-9995.2001.00935.x.
3
Advances in food allergy oral immunotherapy: toward tolerance.
Curr Opin Immunol. 2016 Oct;42:119-123. doi: 10.1016/j.coi.2016.08.002. Epub 2016 Oct 13.
4
New developments in immunotherapies for food allergy.
Immunotherapy. 2015;7(8):913-22. doi: 10.2217/IMT.15.55. Epub 2015 Aug 13.
5
Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy.
Curr Allergy Asthma Rep. 2014 Dec;14(12):486. doi: 10.1007/s11882-014-0486-9.
6
Food allergy-From food avoidance to active treatment.
Scand J Immunol. 2020 Jan;91(1):e12824. doi: 10.1111/sji.12824. Epub 2019 Nov 24.
7
Advances in immunotherapy for food allergy.
Discov Med. 2012 Sep;14(76):159-65.
8
Interventional Therapies for the Treatment of Food Allergy.
Immunol Allergy Clin North Am. 2018 Feb;38(1):77-88. doi: 10.1016/j.iac.2017.09.006. Epub 2017 Oct 23.
9
Sublingual and Patch Immunotherapy for Food Allergy.
Immunol Allergy Clin North Am. 2020 Feb;40(1):135-148. doi: 10.1016/j.iac.2019.09.008.
10
Future therapies for food allergy.
Przegl Lek. 2013;70(12):1065-70.
引用本文的文献
1
The safety and efficacy of oral immunotherapy compared to epicutaneous immunotherapy in peanut allergen desensitisation amongst the paediatric cohort-a narrative review.
Front Allergy. 2025 May 20;6:1613237. doi: 10.3389/falgy.2025.1613237. eCollection 2025.
2
Overview of evidence in prevention and aetiology of food allergy: a review of systematic reviews.
Int J Environ Res Public Health. 2013 Nov 4;10(11):5781-806. doi: 10.3390/ijerph10115781.
3
Specific oral desensitization in children with IgE-mediated cow's milk allergy. Evolution in one year.
Eur J Pediatr. 2012 Sep;171(9):1389-95. doi: 10.1007/s00431-012-1739-z. Epub 2012 May 11.
本文引用的文献
1
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11.
2
Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up.
Allergol Int. 2010 Mar;59(1):43-51. doi: 10.2332/allergolint.09-OA-0107. Epub 2010 Nov 25.
3
Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.
Nat Rev Immunol. 2009 Dec;9(12):883-9. doi: 10.1038/nri2660.
4
Adverse reactions during peanut oral immunotherapy home dosing.
J Allergy Clin Immunol. 2009 Dec;124(6):1351-2. doi: 10.1016/j.jaci.2009.09.042.
5
SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).
J Exp Med. 1935 Nov 30;62(6):733-50. doi: 10.1084/jem.62.6.733.
6
The multinational birth cohort of EuroPrevall: background, aims and methods.
Allergy. 2010 Apr;65(4):482-90. doi: 10.1111/j.1398-9995.2009.02171.x. Epub 2009 Sep 30.
7
Clinical efficacy and immune regulation with peanut oral immunotherapy.
J Allergy Clin Immunol. 2009 Aug;124(2):292-300, 300.e1-97. doi: 10.1016/j.jaci.2009.05.022. Epub 2009 Jul 3.
8
An overview of cow's milk allergy in children.
Swiss Med Wkly. 2009 May 30;139(21-22):300-7. doi: 10.4414/smw.2009.12258.
9
Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
J Allergy Clin Immunol. 2009 Aug;124(2):286-91, 291.e1-6. doi: 10.1016/j.jaci.2009.03.045. Epub 2009 May 27.
10
Mechanisms of foxp3+ T regulatory cell-mediated suppression.
Immunity. 2009 May;30(5):636-45. doi: 10.1016/j.immuni.2009.04.010.
Zotero 插件